Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An Epstein-Barr virus-associated mature T-cell lymphoproliferative group of disorders affecting children. It occurs with increased frequency in Asians and Native Americans. It includes the systemic EBV-positive T-cell lymphoma of childhood and the hydroa vacciniforme-like lymphoma.
Biomarker and diagnostic research for EBV-positive T-cell lymphoproliferative disorder of childhood has been reported in the published literature.
No clinical trials have been registered for EBV-positive T-cell lymphoproliferative disorder of childhood.
10 publications have been identified in PubMed for EBV-positive T-cell lymphoproliferative disorder of childhood. Research spans Case Report / Case Series (44%), Review / Meta-Analysis (22%), and Diagnostic / Biomarker (11%).
Guan P (2026). [PMID: 41729084](https://pubmed.ncbi.nlm.nih.gov/41729084/). *JCI Insight*. [Diagnostic / Biomarker]
Luniewski A (2026). [PMID: 41657941](https://pubmed.ncbi.nlm.nih.gov/41657941/). *Lymphatics*. [Basic Science / Preclinical]
García-González S (2025). [PMID: 39938780](https://pubmed.ncbi.nlm.nih.gov/39938780/). *Actas Dermosifiliogr*. [Review / Meta-Analysis]
Ma L (2025). [PMID: 41306545](https://pubmed.ncbi.nlm.nih.gov/41306545/). *Front Pediatr*. [Case Report / Case Series]
Coman D (2025). [PMID: 41725795](https://pubmed.ncbi.nlm.nih.gov/41725795/). *Can Liver J*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Oct 4, 2026, 12:14 AM UTC
Common questions about EBV-positive T-cell lymphoproliferative disorder of childhood
Dilmurat D (2024). [PMID: 38956696](https://pubmed.ncbi.nlm.nih.gov/38956696/). *Ital J Pediatr*. [Epidemiology / Natural History]
Jimenez A (2024). [PMID: 39185704](https://pubmed.ncbi.nlm.nih.gov/39185704/). *Pediatr Blood Cancer*. [Case Report / Case Series]
Shi L (2024). [PMID: 39380854](https://pubmed.ncbi.nlm.nih.gov/39380854/). *AME Case Rep*. [Case Report / Case Series]
Cao P (2024). [PMID: 39196630](https://pubmed.ncbi.nlm.nih.gov/39196630/). *J Pediatr Hematol Oncol*. [Review / Meta-Analysis]
AI-curated news mentioning EBV-positive T-cell lymphoproliferative disorder of childhood
Updated Mar 18, 2026
A new publication reviews the epidemiology, pathophysiology, and diagnosis of T-cell lymphoproliferative disorders. This comprehensive analysis provides insights into the underlying mechanisms and clinical implications of these rare diseases.